Team:UCL/Background

From 2013.igem.org

(Difference between revisions)
 
(7 intermediate revisions not shown)
Line 73: Line 73:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url('#');">
+
<div class="col_illustration" style="background-image:url('https://static.igem.org/mediawiki/2013/3/3a/Holding_hands.jpg');">
</div>
</div>
Line 93: Line 93:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url(''https://static.igem.org/mediawiki/2013/4/4b/Img1.png'');">
+
<div class="col_illustration" style="background-image:url('https://static.igem.org/mediawiki/2013/e/e4/Amyloid_plaques_alzheimer_disease_HE_stain.jpg');">
</div>
</div>
Line 112: Line 112:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url('#');">
+
<div class="col_illustration" style="background-image:url('https://static.igem.org/mediawiki/2013/0/0b/Microglia_and_neurons.jpg');">
</div>
</div>
Line 131: Line 131:
</div>
</div>
-
<img src="https://static.igem.org/mediawiki/2013/7/7f/Homepage_poster.png"><div class="CLASS" style="height:600px;width:600px"><a href="https://static.igem.org/mediawiki/2013/7/7f/Homepage_poster.png" data-lightbox="TITLE" title="CAPTION"></a></div>
 
<!-- END CONTENT ---------------------------------------------------------------------------------------------------->
<!-- END CONTENT ---------------------------------------------------------------------------------------------------->

Latest revision as of 17:33, 19 September 2013

RELATED NEUROSCIENCE

Neuro-genetic engineering

Our project this year blends the fields of synthetic biology and neuroscience. We aim to demonstrate that genetic engineering techniques can be applied to the central nervous system, in order to rectify abnormalities in, for example, the brain on a cellular and/or macromolecular level. Such a novel application of synthetic biology could offer new ways to treat certain brain diseases, such as Alzheimer’s disease, for which modern pharmaceutical treatment is purely symptomatic.

Click the abstracts below to read more.